FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
-7.38%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$17B
AUM Growth
+$17B
(-5.9%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
4.93%
Top 10 Holdings %
Top 10 Hldgs %
29.01%
Holding
344
New
22
Increased
43
Reduced
37
Closed
29
Top Buys
| 1 |
Dynatrace
DT
|
$309M |
| 2 |
CoStar Group
CSGP
|
$300M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$284M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$274M |
| 5 |
Clarivate
CLVT
|
$220M |
Top Sells
| 1 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
$411M |
| 2 |
RTX Corp
RTX
|
$335M |
| 3 |
CERN
Cerner Corp
CERN
|
$312M |
| 4 |
Broadcom
AVGO
|
$257M |
| 5 |
PLAN
Anaplan, Inc.
PLAN
|
$102M |
Sector Composition
| 1 | Healthcare | 33.38% |
| 2 | Technology | 19.03% |
| 3 | Financials | 15.88% |
| 4 | Industrials | 9.93% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adobe
ADBE
$148B
| $260M | 1.41% |
710,772
+4,400
| +0.6% | +$1.61M |
|
27
Blackstone
BX
$131B
| $257M | 1.4% |
2,821,451
-102,000
| -3% | -$9.31M |
|
28
Aon
AON
$80.6B
| $250M | 1.36% |
928,486
-85,500
| -8% | -$23.1M |
|
29
Sherwin-Williams
SHW
$90.5B
| $238M | 1.29% |
1,062,592
-162,500
| -13% | -$36.4M |
|
|
CHNG
30
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $234M | 1.27% |
10,165,000
+6,891,400
| +211% | +$159M |
|
31
ServiceNow
NOW
$191B
| $233M | 1.26% |
490,150
-2,200
| -0.4% | -$1.05M |
|
32
Exelixis
EXEL
$9.95B
| $212M | 1.15% |
10,174,273
-345,788
| -3% | -$7.2M |
|
33
New York Times
NYT
$9.58B
| $192M | 1.04% |
6,880,804
-457,550
| -6% | -$12.8M |
|
34
KE Holdings
BEKE
$21.8B
| $179M | 0.97% |
9,958,500
+1,245,000
| +14% | +$22.3M |
|
|
XYZ
35
Block, Inc.
XYZ
$46.2B
| $174M | 0.95% |
2,839,000
+643,000
| +29% | +$39.5M |
|
36
Avantor
AVTR
$8.74B
| $164M | 0.89% |
5,279,464
+1,472,352
| +39% | +$45.8M |
|
|
COHR
37
DELISTED
Coherent Inc
COHR
| $154M | 0.83% |
577,982
+106,449
| +23% | +$28.3M |
|
38
Jazz Pharmaceuticals
JAZZ
$7.99B
| $144M | 0.78% |
920,100
+591,100
| +180% | +$92.2M |
|
39
Lufax Holding
LU
$2.66B
| $142M | 0.77% |
23,740,399
+1,706,000
| +8% | +$10.2M |
|
40
Beam Therapeutics
BEAM
$1.9B
| $134M | 0.73% |
3,472,271
+877,884
| +34% | +$34M |
|
41
Labcorp
LH
$22.8B
| $122M | 0.66% |
518,714
+88,700
| +21% | +$20.8M |
|
42
CVS Health
CVS
$93B
| $115M | 0.63% |
1,246,259
+59,976
| +5% | +$5.56M |
|
|
VMW
43
DELISTED
VMware, Inc
VMW
| $115M | 0.62% |
+1,010,000
| New | +$115M |
|
44
Alnylam Pharmaceuticals
ALNY
$58.6B
| $115M | 0.62% |
787,910
-235,963
| -23% | -$34.4M |
|
45
S&P Global
SPGI
$165B
| $111M | 0.6% |
+329,000
| New | +$111M |
|
|
MANT
46
DELISTED
Mantech International Corp
MANT
| $92.7M | 0.5% |
971,595
+596,595
| +159% | +$56.9M |
|
47
United Therapeutics
UTHR
$17.7B
| $92.5M | 0.5% |
392,696
+13,000
| +3% | +$3.06M |
|
48
TSMC
TSM
$1.2T
| $92.1M | 0.5% |
1,126,125
+98,000
| +10% | +$8.01M |
|
49
Sarepta Therapeutics
SRPT
$1.98B
| $88.8M | 0.48% |
1,185,051
+193,076
| +19% | +$14.5M |
|
50
Bruker
BRKR
$4.45B
| $88.3M | 0.48% |
1,406,800
+345,000
| +32% | +$21.7M |
|